PX1 Research provides academic institutions, biotechnology firms, and independent laboratories in Connecticut with verified, high-purity TB-500 for preclinical research. All research compounds are synthesized in the United States and subject to rigorous ISO 17025 analytical testing to ensure lot-to-lot consistency.
PX1 Research provides academic institutions, biotechnology firms, and independent laboratories in Connecticut with verified, high-purity TB-500 for preclinical research. All research compounds are synthesized in the United States and subject to rigorous ISO 17025 analytical testing to ensure lot-to-lot consistency.
Connecticut harbors one of the premier biomedical research ecosystems in the United States, anchored by world-class universities in New Haven and Storrs, alongside a expanding life science hub throughout the Hartford and coastal regions. For principal investigators and laboratory managers operating in these high-stakes environments, obtaining reliable, high-purity compounds is a fundamental requirement. Sourcing the TB-500 peptide requires a vendor capable of supplying transparent, batch-specific analytical documentation and rapid domestic distribution.
PX1 Research serves Connecticut research facilities by eliminating the uncertainties of international supply chains. Domestic synthesis combined with fulfillment from our California and Arizona distribution hubs ensures that orders bypass international customs clearance entirely. Orders placed before cut-off times ship same-day Monday through Friday, delivering consistent supply continuity to laboratories managing tight assay schedules across Connecticut.
TB-500 is a synthetic peptide derivative representing the active domain of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid peptide encoded by the TMSB4X gene. The sequence of TB-500 focuses specifically on the N-terminal fragment, primarily containing the central actin-binding sequence LKKTETQ. This truncated peptide motif retains the key biological activities of the parent protein while offering altered molecular weight and solubility profiles advantageous for specific in vitro assays.
With a reduced molecular weight relative to the full-length protein, TB-500 displays distinct diffusion kinetics in tissue culture models. Laboratory investigations frequently utilize this peptide sequence to isolate the specific cellular pathways driven by the primary active motif of Thymosin Beta-4 without the conformational complexity of the complete protein chain.
At the cellular level, TB-500 operates primarily through its interaction with globular actin (G-actin). Actin is a structural protein fundamental to cell morphology, motility, and structural integrity. In vitro studies demonstrate that the active fragment binds monomeric G-actin in a 1:1 complex, preventing its spontaneous polymerization into filamentous actin (F-actin) until specific cellular signals trigger cytoskeletal rearrangement.
By sequestering G-actin monomers, TB-500 regulates the dynamic pool of actin available within the cytoplasm. Preclinical models indicate that this regulation directly influences cell migration—a necessary prerequisite for tissue remodeling. When cells undergo structural reorganization during in vitro scratch assays or cellular migration experiments, the controlled availability of actin monomers permits rapid lamellipodia formation, facilitating directed cell movement across extracellular matrices.
In preclinical research models, TB-500 is extensively studied as a regeneration peptide. Investigations focus on its capacity to promote cell migration, blood-vessel formation (angiogenesis), and tissue flexibility during soft-tissue and muscle-fiber recovery protocols. Rodent and cell-culture models evaluating mechanical stress in collagenous tissue suggest that exposure to the LKKTETQ fragment enhances the rate of endothelial cell capillary-like tube formation.
Furthermore, animal studies investigating tendon and muscle fiber repair suggest that TB-500 modulated pathways contribute to improved flexibility and structural alignment during the matrix remodeling phase. By encouraging neo-vascularization around damaged micro-environments, the compound helps maintain oxygenation and nutrient transport in soft-tissue models. Researchers interested in broader cellular repair mechanisms often cross-reference these findings within our comprehensive PX1 research library.
Maintaining rigorous experimental reproducibility requires research reagents with confirmed identity and purity. PX1 Research subjects every batch of TB-500 to dual analytical verification via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) conducted by independent, ISO 17025 accredited laboratories located in the USA.
HPLC analysis confirms chemical purity, ensuring that every vial meets or exceeds our strict purity thresholds (typically ≥98%). Mass spectrometry confirms molecular mass and sequence integrity, ruling out truncated sequences or synthesis side-products. Additionally, because bacterial endotoxins can confound cell culture viability and induce non-specific inflammatory responses in vitro, every lot undergoes Chromogenic LAL assay testing to verify endotoxin levels remain below stringent laboratory limits (<0.01 EU/mg).
In tissue regeneration and cellular mobility research, TB-500 is frequently evaluated alongside or in contrast to other cell signaling signaling peptides. Understanding the distinct mechanical targets of each compound allows investigators to design robust, multi-variable experimental protocols.
While TB-500 primarily targets actin dynamics and endothelial cell migration, BPC-157 functions via distinct growth factor receptor pathways and nitric oxide signaling modulation. Concurrently, GHK-Cu is investigated for its copper-binding capacity and modulation of gene expression related to collagen synthesis, whereas full-length Thymosin Beta-4 offers the complete 43-amino-acid structural dynamics. Evaluating these compounds in parallel assays provides researchers with a comprehensive view of extracellular matrix remodeling.
TB-500 is supplied as a lyophilized (freeze-dried) sterile powder in sealed glass serum vials to maximize shelf stability. To maintain compound integrity upon arrival at Connecticut research facilities, proper storage and handling procedures must be observed.
Lyophilized vials should be stored at -20°C prior to reconstitution. When preparing solutions for laboratory assays, reconstitution should be performed using sterile, laboratory-grade solvents such as bacteriostatic water or sterile normal saline under a laminar flow hood. After reconstitution, gentle swirling is recommended; rigorous vortexing or mechanical agitation should be avoided to prevent peptide shear. Reconstituted solutions should be aliquoted into single-use microcentrifuge tubes to avoid repeated freeze-thaw cycles and stored at 2°C to 8°C for short-term use, or -80°C for long-term preservation.
Biotechnology laboratories, university departments, and contract research organizations (CROs) in Connecticut require streamlined procurement processes that accommodate institutional purchase orders and compliance requirements. PX1 Research provides specialized administrative support to facilitate direct purchasing and automated reordering.
For high-volume laboratories, department-wide research projects, or ongoing long-term animal studies, PX1 Research provides bulk wholesale options with scalable pricing structures. All shipments originate from our domestic California and Arizona facilities, packaged in climate-resilient insulation to protect lyophilized integrity during transit to Connecticut.
How is TB-500 shipped to research institutions in Connecticut?
TB-500 orders ship directly from PX1 Research fulfillment facilities in California and Arizona via priority domestic carriers. Orders placed before daily cut-off times ship same-day Monday through Friday, arriving at Connecticut laboratories without international customs delays.
Is TB-500 approved for human consumption or clinical use in Connecticut?
No. TB-500 supplied by PX1 Research is strictly sold as a research compound intended for in vitro, laboratory, and preclinical research applications only. It is not licensed, labeled, or intended for human consumption, therapeutic use, or clinical administration.
What documentation is provided with PX1 Research TB-500 lots?
Every lot of TB-500 is accompanied by a batch-specific Certificate of Analysis (COA) issued by an independent ISO 17025 accredited laboratory. The COA includes HPLC chromatograms, mass spectrometry reports, and chromogenic LAL endotoxin test results.
What is the primary structural difference between TB-500 and Thymosin Beta-4?
Thymosin Beta-4 is the full-length, naturally occurring 43-amino-acid peptide, whereas TB-500 is a synthetic peptide containing the primary active LKKTETQ domain responsible for actin binding and cell motility.
What diluent should be used for reconstituting TB-500 for in vitro assays?
Laboratory protocols typically utilize sterile bacteriostatic water or sterile normal saline (0.9% NaCl) for reconstituting lyophilized TB-500 under sterile aseptic conditions.
What are the endotoxin thresholds for PX1 Research TB-500?
PX1 Research enforces strict purity standards requiring endotoxin levels to test below 0.01 EU/mg via Chromogenic LAL assay to prevent cellular toxicity in sensitive research models.
Can Connecticut academic facilities establish wholesale procurement accounts?
Yes. Universities, CROs, and private research institutions in Connecticut can establish dedicated wholesale accounts for tiered volume pricing, institutional PO processing, and recurring shipments.
How should lyophilized TB-500 be stored upon receipt at the lab?
Lyophilized TB-500 should be stored in a freezer at -20°C upon receipt. Desiccant storage is recommended to prevent moisture absorption prior to reconstitution.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.